EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mao II who wrote (1661)	2/12/1999 6:54:00 AM
From: Pluvia	Read Replies (3) of 2135

More Bad News for ENMD on the Wire this am... dljdirect.com *************************************** Lehman Brothers analyst, Dr. Eric Ende, said favorable results for the two drugs have only been seen in mice and not in people, making it far too early to bank on EntreMed's discoveries. Ende, noting that the drugs are supposed to reduce the size of tumors, said the NCI report merely indicated that endostatin inhibited tumor growth. "Inhibition does not equal regression," he said. "I wouldn't touch this thing (EntreMed shares) until this stuff not only goes into humans, but shows effectiveness inhumans." On Tuesday, the stock crumbled after EntreMed's angiostatin development partner Bristol-Myers said it could no longer finance development of the drug because it was too difficult to produce in large enough quantities to conduct clinical trials. But Bristol-Myers said it retains an option to come back and help develop angiostatin if EntreMed can produce enough stable product to be commercially useful.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next